Delivery Order SPE2DB24D8003-SPE2DB25FJVCP
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,584.98 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). The contract is priced on a firm fixed-price basis with an ultimate completion date of August 22, 2025, and was awarded on August 21, 2025. This delivery order carries no set-aside designation and represents a straightforward pharmaceutical procurement...
- The Defense Logistics Agency awarded a $5.74K delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for Xulane 150-35 mcg/day transdermal patches (3-count units). This contract is not set-aside and carries a firm fixed price structure with an ultimate completion date of July 23, 2025. The delivery order was issued on July 22, 2025, and falls under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $2,116.14 firm fixed price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The award is not set aside and has an ultimate completion date of May 21, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,298.29, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. It is a firm fixed-price contract with a performance period extending to March 17, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, holding a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,266.06 fixed-price delivery order is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to supply a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,686.83, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, having been awarded a significant Indefinite...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $2,506.81 firm fixed-price contract is for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract is not set aside and is part of DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,640.80, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Dakota Drug, Inc., identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop...
- This federal contract award, identified as SPE2DB24D8002|SPE2DB25FJMRZ, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, which is a Firm Fixed Price Delivery Order, is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a ceiling value of $4,112.43 and a completion date of November 14, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...
- This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYXA, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,866.98 Firm Fixed Price Delivery Order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop...